Sana Biotechnology
SANA
78 hedge funds and large institutions have $3.1B invested in Sana Biotechnology in 2021 Q1 according to their latest regulatory filings, with 78 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
49.34% more ownership
Funds ownership: 0% → 49.34% (+49%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
+$1.11B |
| 2 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$331M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$325M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$284M |
| 5 |
Public Sector Pension Investment Board (PSP Investments)
Montreal,
Quebec, Canada
|
+$135M |
Top Sellers
SANA Hedge Fund Activity: Q1 2021 in Review
78 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Sana Biotechnology (SANA) for Q1 2021, worth a combined $3.1B.
Buyers outnumbered sellers: 78 funds opened new SANA positions and 0 closed out — a net gain of 78 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Flagship Pioneering, opening a new position worth an estimated $1.11B.
- 78 institutional investors held Sana Biotechnology (SANA) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $3.1B of Sana Biotechnology stock for Q1 2021.
- 78 funds opened new Sana Biotechnology positions in Q1 2021 and 0 closed out, a net change of +78 holders.
- The largest Sana Biotechnology buyer in Q1 2021 was Flagship Pioneering, an estimated $1.11B added.
Based on aggregated 13F filings for Q1 2021.